How much is the Syphilis Testing Market market?

The syphilis testing market market size is estimated to grow at $$ 2220.61 mn in 2023. Read More

What is the growth rate of the Syphilis Testing Market market?

The growth rate of the syphilis testing market year-over-year is 6.7%. Read More

Which region held the largest market share in the Syphilis Testing Market market?

North America is the region to held the largest market share with 42% growth. Read More

Who are the key players in the Syphilis Testing Market market?

Abbott Laboratories, AdvaCare Pharma, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., .... Read More

Which Segment has the largest market share in the Syphilis Testing Market market?

End-user is the segment that has the largest market share in the market. Read More

Syphilis Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Oct 2023
Pages: 164
SKU: IRTNTR40538

Enjoy complimentary customisation on priority with our Enterprise License!

Syphilis Testing Market Size 2024-2028

The syphilis testing market size is forecast to increase by USD 2.22 billion at a CAGR of 6.7% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. The rise in the prevalence of syphilis, particularly among high-risk populations and those with undiagnosed or untreated HIV, is a major factor fueling market growth. Advancements in syphilis testing technologies, such as rapid point-of-care tests and molecular diagnostic tests, are also contributing to market expansion. However, the high cost of syphilis diagnostic tests remains a challenge, limiting access to testing in resource-limited settings and among underserved populations. To address this challenge, initiatives to increase funding for syphilis testing and research, as well as the development of affordable testing technologies, are essential. Overall, the market is expected to continue growing due to the increasing burden of syphilis and the ongoing advancements in testing technologies.

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global syphilis testing market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global syphilis testing market 2018 - 2022 ($ million)

4.2 End-user Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.3 Technology Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Technology Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user

6.3 Primary and secondary syphilis - Market size and forecast 2023-2028
- Exhibit 34: Chart on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Primary and secondary syphilis - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Primary and secondary syphilis - Year-over-year growth 2023-2028 (%)

6.4 Latent and tertiary syphilis - Market size and forecast 2023-2028
- Exhibit 38: Chart on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Latent and tertiary syphilis - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Latent and tertiary syphilis - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by End-user
- Exhibit 42: Market opportunity by End-user ($ million)
- Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

7.1 Market segments
- Exhibit 44: Chart on Technology - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Technology - Market share 2023-2028 (%)

7.2 Comparison by Technology
- Exhibit 46: Chart on Comparison by Technology
- Exhibit 47: Data Table on Comparison by Technology

7.3 Laboratory testing/conventional testing - Market size and forecast 2023-2028
- Exhibit 48: Chart on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Laboratory testing/conventional testing - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Laboratory testing/conventional testing - Year-over-year growth 2023-2028 (%)

7.4 POC testing - Market size and forecast 2023-2028
- Exhibit 52: Chart on POC testing - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on POC testing - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on POC testing - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on POC testing - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Technology
- Exhibit 56: Market opportunity by Technology ($ million)
- Exhibit 57: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 107: Abbott Laboratories - Overview
- Exhibit 108: Abbott Laboratories - Business segments
- Exhibit 109: Abbott Laboratories - Key news
- Exhibit 110: Abbott Laboratories - Key offerings
- Exhibit 111: Abbott Laboratories - Segment focus

12.4 Beckman Coulter Inc.
- Exhibit 112: Beckman Coulter Inc. - Overview
- Exhibit 113: Beckman Coulter Inc. - Product / Service
- Exhibit 114: Beckman Coulter Inc. - Key offerings

12.5 Becton Dickinson and Co.
- Exhibit 115: Becton Dickinson and Co. - Overview
- Exhibit 116: Becton Dickinson and Co. - Business segments
- Exhibit 117: Becton Dickinson and Co. - Key news
- Exhibit 118: Becton Dickinson and Co. - Key offerings
- Exhibit 119: Becton Dickinson and Co. - Segment focus

12.6 Bio Rad Laboratories Inc.
- Exhibit 120: Bio Rad Laboratories Inc. - Overview
- Exhibit 121: Bio Rad Laboratories Inc. - Business segments
- Exhibit 122: Bio Rad Laboratories Inc. - Key news
- Exhibit 123: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 124: Bio Rad Laboratories Inc. - Segment focus

12.7 bioLytical Laboratories Inc.
- Exhibit 125: bioLytical Laboratories Inc. - Overview
- Exhibit 126: bioLytical Laboratories Inc. - Product / Service
- Exhibit 127: bioLytical Laboratories Inc. - Key offerings

12.8 Bloodworks Northwest
- Exhibit 128: Bloodworks Northwest - Overview
- Exhibit 129: Bloodworks Northwest - Business segments
- Exhibit 130: Bloodworks Northwest - Key offerings
- Exhibit 131: Bloodworks Northwest - Segment focus

12.9 Danaher Corp.
- Exhibit 132: Danaher Corp. - Overview
- Exhibit 133: Danaher Corp. - Business segments
- Exhibit 134: Danaher Corp. - Key news
- Exhibit 135: Danaher Corp. - Key offerings
- Exhibit 136: Danaher Corp. - Segment focus

12.10 DiaSorin SpA
- Exhibit 137: DiaSorin SpA - Overview
- Exhibit 138: DiaSorin SpA - Business segments
- Exhibit 139: DiaSorin SpA - Key news
- Exhibit 140: DiaSorin SpA - Key offerings
- Exhibit 141: DiaSorin SpA - Segment focus

12.11 F. Hoffmann La Roche Ltd.
- Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus

12.12 Hologic Inc.
- Exhibit 147: Hologic Inc. - Overview
- Exhibit 148: Hologic Inc. - Business segments
- Exhibit 149: Hologic Inc. - Key news
- Exhibit 150: Hologic Inc. - Key offerings
- Exhibit 151: Hologic Inc. - Segment focus

12.13 Meril Life Sciences Pvt. Ltd.
- Exhibit 152: Meril Life Sciences Pvt. Ltd. - Overview
- Exhibit 153: Meril Life Sciences Pvt. Ltd. - Product / Service
- Exhibit 154: Meril Life Sciences Pvt. Ltd. - Key offerings

12.14 Omega Diagnostics Group Plc
- Exhibit 155: Omega Diagnostics Group Plc - Overview
- Exhibit 156: Omega Diagnostics Group Plc - Product / Service
- Exhibit 157: Omega Diagnostics Group Plc - Key offerings

12.15 OriGene Technologies Inc.
- Exhibit 158: OriGene Technologies Inc. - Overview
- Exhibit 159: OriGene Technologies Inc. - Product / Service
- Exhibit 160: OriGene Technologies Inc. - Key offerings

12.16 Siemens Healthineers AG
- Exhibit 161: Siemens Healthineers AG - Overview
- Exhibit 162: Siemens Healthineers AG - Business segments
- Exhibit 163: Siemens Healthineers AG - Key news
- Exhibit 164: Siemens Healthineers AG - Key offerings
- Exhibit 165: Siemens Healthineers AG - Segment focus

12.17 Thermo Fisher Scientific Inc.
- Exhibit 166: Thermo Fisher Scientific Inc. - Overview
- Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 168: Thermo Fisher Scientific Inc. - Key news
- Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 171: Inclusions checklist
- Exhibit 172: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 173: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 174: Research methodology
- Exhibit 175: Validation techniques employed for market sizing
- Exhibit 176: Information sources